Survival of cervical cancer patients in Brunei Darussalam: 2002-2017

被引:2
作者
Lee, Shirley H. F. [1 ]
Rahim, Nurlaylasahira Abdul [1 ,2 ]
Ong, Sok King [3 ]
Rahman, Hanif Abdul [1 ,4 ]
Naing, Lin [1 ]
机构
[1] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Tungku Link Rd, Bandar Seri Begawan BE1410, Brunei
[2] Univ Southampton, Sch Med, Univ Rd, Southampton SO17 1BF, England
[3] Minist Hlth, NCD Prevent Unit, Commonwealth Dr, Bandar Seri Begawan BB3910, Brunei
[4] Univ Michigan, Sch Nursing & Stat Online Computat Resource, Ann Arbor, MI USA
关键词
Cervical cancer; Survival rate; Survival duration; Brunei Darussalam; Cancer registry; WOMEN; RISK;
D O I
10.1016/j.heliyon.2023.e16080
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective:Cervical cancer is the fourth leading cause of cancer deaths among Bruneian women. This study aims to investigate the survival rate of cervical cancer patients in Brunei Darussalam between 2002 and 2017, to compare survival of cervical cancer patients between two periods: 2002-2009 and 2010-2017 and to identify prognostic factors of cervical cancer. Methods:A retrospective cohort study on cervical cancer patients registered in Brunei Darussalam Cancer Registry between 2002 and 2017. De-identified data from the registry was extracted and survival analysis was performed using Kaplan-Meier estimator, log-rank test and multiple Cox regression analysis. Results:The 1-, 3- and 5-year survival rates of cervical cancer patients in Brunei Darussalam were 87.3%, 77.4% and 72.5% respectively from 2002 to 2017. The 5-year survival rate for 2002-2009 and 2010-2017 were 77.3% and 69.1% respectively. The risk of mortality was significantly higher in 2010-2017 compared to 2002-2009 after adjusting for variables (Adjusted HR = 1.59; 95% CI: 1.08, 2.40; p = 0.019). Patients with distant cancer (Adjusted HR = 11.21; 95% CI: 6.18, 20.30; p < 0.001) had the highest risk of mortality. Conclusion:The 5-year survival rate of cervical cancer patients in Brunei Darussalam was 72.5%, which ranks relatively high globally. However, increased mortality among elderly patients, and patients diagnosed with cervical cancers at the later stages, calls for public health efforts to raise awareness, early detection, and disease management.
引用
收藏
页数:10
相关论文
共 27 条
[1]  
Albero G., 2019, BRUNEI HUMAN PAPILLO
[2]  
[Anonymous], 2020, LANCET, V395, P312, DOI 10.1016/S0140-6736(20)30247-6
[3]   Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J].
Arbyn, Marc ;
Weiderpass, Elisabete ;
Bruni, Laia ;
de Sanjose, Silvia ;
Saraiya, Mona ;
Ferlay, Jacques ;
Bray, Freddie .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E191-E203
[4]  
B. Ministry of Health, 2017, HLTH INF BOOKL
[5]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[6]   Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area [J].
Bulk, S ;
Visser, O ;
Rozendaal, L ;
Verheijen, RHM ;
Meijer, CJLM .
BRITISH JOURNAL OF CANCER, 2003, 89 (05) :834-839
[7]  
Cervical Cancer Action, 2009, NEW OPTIONS CERVICAL
[8]   Human Papillomavirus vaccine coverage among female students in Brunei Darussalam: results from the first 4 years of the national school-based vaccination programme [J].
Chaw, Li Ling ;
Lim, Shaun Tze Wei ;
Yussof, Siti Rosemawati Md .
HELIYON, 2019, 5 (10)
[9]   Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing [J].
Chrysostomou, Andreas C. ;
Stylianou, Dora C. ;
Constantinidou, Anastasia ;
Kostrikis, Leondios G. .
VIRUSES-BASEL, 2018, 10 (12)
[10]   A Population-Based Evaluation of Cervical Screening in the United States: 2008-2011 [J].
Cuzick, Jack ;
Myers, Orrin ;
Hunt, William C. ;
Robertson, Michael ;
Joste, Nancy E. ;
Castle, Philip E. ;
Benard, Vicki B. ;
Wheeler, Cosette M. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (05) :765-773